Atlas Trials

Interferon α for the Therapy of Minimal Residual Disease

Clinical trial NCT02185261 · UNKNOWN

Trial details

NCT number
NCT02185261
Sponsor
Peking University People's Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Leukemia
Start date
2014-06-01
Primary completion
2021-06-01
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.